2025年8月22日，福赛科技(301529.SZ)发布2025年中报。 公司营业总收入为8.20亿元，较去年同报告期营业总收入增加2.14亿元，实现4年连续上涨，同比较去年同期上涨35.41%。归母净利润为6329.54万元，较去 年同报告期归母净利润增加1688.98万元，实现3年连续上涨，同比较去年同期上涨36.40%。经营活动现金净流入为1.57亿元，较去年同报告期经营活动现金 净流入增加1.57亿元。 公司最新资产负债率为39.28%。 公司最新毛利率为24.66%，较上季度毛利率增加0.30个百分点。最新ROE为4.85%，较去年同期ROE增加1.11个百分点。 公司摊薄每股收益为0.76元，较去年同报告期摊薄每股收益增加0.21元，同比较去年同期上涨38.18%。 公司最新总资产周转率为0.40次，较去年同期总资产周转率增加0.07次，同比较去年同期上涨22.72%。最新存货周转率为2.23次。 公司股东户数为8482户，前十大股东持股数量为5790.41万股，占总股本比例为68.25%，前十大股东持股情况如下： | 序号 | 股东名称 | 持股 | | --- | --- | --- | | ...

2025年8月21日，利元亨(688499.SH)发布2025年中报。 公司营业总收入为15.29亿元，较去年同报告期营业总收入减少3.24亿元，同比较去年同期下降17.48%。归母净利润为3341.02万元。经营活动现金净流入为 2.24亿元。 公司最新总资产周转率为0.18次，较去年同期总资产周转率减少0.01次，同比较去年同期下降6.59%。最新存货周转率为0.40次，较去年同期存货周转率减少 0.07次，同比较去年同期下降14.84%。 公司股东户数为2.24万户，前十大股东持股数量为7042.68万股，占总股本比例为41.74%，前十大股东持股情况如下： | 序号 | 股东名称 | 持股 | | --- | --- | --- | | l | 惠州市利元亨投资有限公司 | 33.4 | | 2 | 宁波梅山保税港区弘邦投资管理合伙企业(有限合伙) | 2.31 | | 3 | 卢家红 | 1.96 | | 4 | 彭凯 | 1.09 | | 5 | 宁波梅山保税港区奕荣投资管理合伙企业(有限合伙) | 0.83 | | 6 | 兴业银行股份有限公司-中航新起航灵活配置混合型证券投资基金 | 0.55 ...

Core Insights - The company reported a total revenue of 8.306 billion yuan for the first half of 2025, an increase of 1.831 billion yuan compared to the same period last year, representing a year-on-year growth of 28.28% [1] - The net profit attributable to shareholders reached 523 million yuan, an increase of 492 million yuan from the same period last year, achieving a remarkable year-on-year increase of 1568.52% [1] - The company experienced a net cash outflow from operating activities of 357 million yuan [1] Financial Ratios - The latest debt-to-asset ratio stands at 62.08%, a decrease of 2.07 percentage points from the previous quarter [3] - The gross profit margin is reported at 16.46%, an increase of 6.98 percentage points compared to the same period last year, marking two consecutive years of growth [3] - The return on equity (ROE) is 9.37%, an increase of 8.82 percentage points year-on-year [3] Earnings Per Share - The diluted earnings per share (EPS) is 1.05 yuan, an increase of 0.99 yuan from the same period last year, achieving a year-on-year growth of 1650.00% [3] Asset Management - The total asset turnover ratio is 0.46 times, an increase of 0.10 times compared to the same period last year, representing a year-on-year growth of 26.84% [3] - The inventory turnover ratio is reported at 2.08 times [3] Shareholder Information - The number of shareholders is 37,400, with the top ten shareholders holding a total of 199 million shares, accounting for 39.90% of the total share capital [3] - The top shareholders include individuals and investment funds, with the largest shareholder holding 16.5 million shares [3]

Core Insights - The company reported a total revenue of 159 million yuan for the first half of 2025, a decrease of 1.58 million yuan compared to the same period last year, representing a year-on-year decline of 0.99% [1] - The net profit attributable to shareholders was -3.52 million yuan, indicating a loss [1] - The net cash inflow from operating activities was -64.99 million yuan [1] Financial Metrics - The latest debt-to-asset ratio is 22.87%, an increase of 1.42 percentage points from the previous quarter [3] - The latest gross profit margin stands at 43.41% [3] - The return on equity (ROE) is -0.32% [3] - The diluted earnings per share (EPS) is -0.01 yuan [3] - The total asset turnover ratio remained flat compared to the same period last year, with a year-on-year decline of 2.14% [3] - The latest inventory turnover ratio is 4.45 times [3] Shareholder Structure - The number of shareholders is 10,200, with the top ten shareholders holding 155 million shares, accounting for 59.06% of the total share capital [3] - The largest shareholder is Tongce Medical Co., Ltd., holding 19.01% [3] - Other significant shareholders include Hangzhou Panyuan Investment Co., Ltd. at 15.33% and Xiamen Silicon Valley Shaohua No.1 Investment Partnership at 10.01% [3]

2025年8月21日，三维化学(002469.SZ)发布2025年中报。 公司营业总收入为12.49亿元。归母净利润为1.20亿元。经营活动现金净流入为2160.95万元，较去年同 报告期经营活动现金净流入减少1.18亿元，同比较去年同期下降84.48%。 公司最新毛利率为19.94%，较上季度毛利率减少0.70个百分点。最新ROE为4.54%。 公司摊薄每股收益为0.19元。 公司最新总资产周转率为0.36次。最新存货周转率为4.06次。 公司股东户数为4.25万户，前十大股东持股数量为2.50亿股，占总股本比例为38.52%，前十大股东持股 情况如下： | 序号 | 股东名称 | 持股比例 | | --- | --- | --- | | 1 | 山东人和投资有限公司 | 21.14% | | 2 | 中国建设银行股份有限公司-华泰柏瑞中证红利低波动交易型开放式指数证券投 资基金 | 4.29% | | 3 | 全国社保基金五零三组合 | 3.08% | | র্ব | 曲思秋 | 2.30% | | 5 | 前海人寿保险股份有限公司-分红保险产品 | 2.11% | | 6 | 华夏基金管理有限公司-社保 ...

Core Insights - The company reported a total revenue of 307 million yuan for the first half of 2025, marking an increase of 45.9 million yuan compared to the same period last year, achieving a 17.6% year-on-year growth [1] - The net profit attributable to shareholders reached 108 million yuan, an increase of 40.1 million yuan from the previous year, reflecting a 59.01% year-on-year growth [1] - The net cash inflow from operating activities was 118 million yuan [1] Financial Metrics - The latest debt-to-asset ratio stands at 11.01% [3] - The gross profit margin is 49.68%, up 0.92 percentage points from the previous quarter, and has increased by 7.59 percentage points year-on-year [3] - The return on equity (ROE) is 6.64%, an increase of 2.14 percentage points compared to the same period last year [3] - The diluted earnings per share (EPS) is 0.64 yuan, up 0.24 yuan year-on-year, representing a 60% increase [3] - The total asset turnover ratio is 0.17 times, an increase of 0.01 times year-on-year, reflecting an 8.35% growth [3] - The inventory turnover ratio is 0.99 times [3] Shareholder Structure - The number of shareholders is 8,278, with the top ten shareholders holding a total of 90.09 million shares, accounting for 53.53% of the total share capital [3] - The largest shareholder is Wuhan Xiwang Biological Engineering Co., Ltd., holding 44.1% of the shares [3]

公司营业总收入为85.47亿元，较去年同报告期营业总收入增加16.61亿元，同比较去年同期上涨 24.13%。归母净利润为2643.49万元，较去年同报告期归母净利润增加6946.84万元，实现2年连续上 涨。经营活动现金净流入为4.54亿元，较去年同报告期经营活动现金净流入增加1.36亿元，实现2年连续 上涨，同比较去年同期上涨42.61%。 公司最新资产负债率为56.80%。 公司最新毛利率为2.10%，较去年同期毛利率增加0.17个百分点，实现2年连续上涨。最新ROE为 0.31%，较去年同期ROE增加0.81个百分点。 2025年8月16日，金能科技(603113.SH)发布2025年中报。 公司摊薄每股收益为0.03元，较去年同报告期摊薄每股收益增加0.08元，实现2年连续上涨。 公司最新总资产周转率为0.44次，较去年同期总资产周转率增加0.06次，同比较去年同期上涨15.93%。 最新存货周转率为5.50次。 公司股东户数为3.31万户，前十大股东持股数量为4.76亿股，占总股本比例为56.09%，前十大股东持股 情况如下： | 序号 | 股东名称 | 持股比例 | | --- | --- | ...

Core Insights - The company reported a total revenue of 440 million yuan for the first half of 2025, an increase of 210 million yuan compared to the same period last year, marking a 91.53% year-on-year growth [1] - The net profit attributable to shareholders reached 30.69 million yuan, up by 37.82 million yuan from the previous year, achieving two consecutive years of growth [1] - The net cash inflow from operating activities was 56.70 million yuan, an increase of 54.57 million yuan year-on-year, also reflecting two consecutive years of growth [1] Financial Ratios - The latest debt-to-asset ratio stands at 18.97% [3] - The gross profit margin is 24.74%, which is an increase of 6.53 percentage points compared to the same period last year [3] - The return on equity (ROE) is 2.49%, up by 3.08 percentage points year-on-year [3] Earnings Per Share and Turnover Ratios - The diluted earnings per share is 0.20 yuan, an increase of 0.25 yuan compared to the same period last year, achieving two consecutive years of growth [3] - The total asset turnover ratio is 0.30 times, an increase of 0.14 times year-on-year, reflecting an 81.89% increase [3] - The inventory turnover ratio is 2.85 times, up by 0.46 times compared to the previous year, representing a 19.20% year-on-year increase [3] Shareholder Information - The number of shareholders is 8,831, with the top ten shareholders holding a total of 95.10 million shares, accounting for 62.61% of the total share capital [3] - The largest shareholder, Luo Xingshun, holds 34.33% of the shares [3]

Financial Performance - The company reported a total revenue of 513 million yuan, an increase of 48.43 million yuan compared to the same period last year, achieving a year-on-year growth of 10.43% [1] - The net profit attributable to shareholders was 73.38 million yuan, up by 3.51 million yuan year-on-year, marking a 5.03% increase [1] - The net cash inflow from operating activities was 118 million yuan, an increase of 16.96 million yuan year-on-year, representing a growth of 16.83% [1] Profitability Metrics - The latest asset-liability ratio stands at 20.29% [3] - The gross profit margin is 28.58%, up by 1.77 percentage points from the previous quarter and 1.24 percentage points from the same period last year [3] - The return on equity (ROE) is 4.22%, an increase of 0.16 percentage points year-on-year [3] - The diluted earnings per share (EPS) is 0.50 yuan, an increase of 0.03 yuan year-on-year, reflecting a growth of 7.45% [3] Efficiency Ratios - The total asset turnover ratio is 0.24 times, an increase of 0.01 times year-on-year, representing a growth of 6.24% [3] - The inventory turnover ratio is 1.70 times, up by 0.18 times year-on-year, achieving an 11.83% increase [3] Shareholder Structure - The number of shareholders is 19,000, with the top ten shareholders holding 97.82 million shares, accounting for 65.39% of the total share capital [3] - The largest shareholder, Xiong Ying, holds 24.84% of the shares, followed by Xiong Jie with 20.41% [3]

Financial Performance - The total revenue for Huarun Pharmaceutical in the first half of 2025 was 624 million yuan, a decrease of 148 million yuan compared to the same period last year, representing a year-on-year decline of 19.13% [1] - The net profit attributable to shareholders was 37.33 million yuan, down 35.88 million yuan from the same period last year, reflecting a year-on-year decrease of 49.01% [1] - The net cash inflow from operating activities was 170 million yuan, an increase of 8.53 million yuan compared to the same period last year, marking a 5.29% year-on-year increase and achieving four consecutive years of growth [1] Profitability and Efficiency Ratios - The latest asset-liability ratio is 58.74%, a decrease of 0.96 percentage points from the previous quarter, but an increase of 15.25 percentage points compared to the same period last year [3] - The latest gross profit margin is 37.73%, an increase of 1.44 percentage points from the previous quarter, achieving two consecutive quarters of growth, but a slight decrease of 0.02 percentage points compared to the same period last year [3] - The latest return on equity (ROE) is 2.79%, an increase of 0.12 percentage points compared to the same period last year [3] - The diluted earnings per share are 0.03 yuan, a decrease of 0.03 yuan compared to the same period last year, reflecting a year-on-year decline of 48.95% [3] - The latest total asset turnover ratio is 0.18 times, an increase of 0.03 times compared to the same period last year, representing a year-on-year increase of 19.72% [3] - The latest inventory turnover ratio is 1.30 times, a decrease of 0.17 times compared to the same period last year, reflecting a year-on-year decline of 11.46% [3] Shareholder Structure - The number of shareholders is 42,000, with the top ten shareholders holding 529 million shares, accounting for 44.77% of the total share capital [3] - The largest shareholder is Xi'an Qujiang Tian Shou Health Investment Partnership, holding 20.00% of the shares [3]